Neuropharmacology

Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine (CBPG), a novel mGlu₅ receptor agonist endowed with mGlu₁ receptor antagonist activity
pp. 917-926(10)
Authors: Mannaioni G.; Attucci S.; Missanelli A.; Pellicciari R.; Corradetti R.; Moroni F.

Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling
pp. 927-933(7)
Authors: Klapstein G.J.; Meldrum B.S.; Mody I.

Modulation of cardiovascular effects produced by nitric oxide and ionotropic glutamate receptor interaction in the nucleus tractus solitarii of rats
pp. 935-941(7)
Authors: Lin H.-C.; Wan F.-J.; Tseng C.-J.

Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms
pp. 943-954(12)
Authors: Del Arco A.; Gonzalez-Mora J.L.; Armas V.R.; Mora F.

Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss
pp. 955-963(9)
Authors: Matsumoto K.; Uzunova V.; Pinna G.; Taki K.; Uzunov D.P.; Watanabe H.; Mienville J.-M.; Guidotti A.; Costa E.

Pharmacological studies on synthetic flavonoids: comparison with diazepam
pp. 965-977(13)
Authors: Griebel G.; Perrault G.; Tan S.; Schoemaker H.; Sanger D.J.

Inhibition of Ca²⁺-activated K⁺ current by clotrimazole in rat anterior pituitary GH₃ cells
pp. 979-989(11)
Authors: Wu S.-N.; Li H.-F.; Jan C.-R.; Shen A.-Y.

Attenuation of opioid receptor-mediated signaling by kainic acid in neural cells: involvement of protein kinase C and intracellular Ca²⁺
pp. 991-998(8)
Authors: Ben L.-H.; Zhao J.; Xin S.-M.; Luo S.-Q.; Pei G.

Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the &unknown; opioid system in the nucleus accumbens of rat
pp. 999-1007(9)
Authors: Dauge V.; Samir A.; Cupo A.; Roques B.P.

Differential modulation of nucleoside transport types in neuroblastoma cells by protein kinase activation
pp. 1009-1015(7)
Authors: Sen R.P.; Delicado E.G.; Miras-Portugal M.T.

Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs)
pp. 1017-1025(9)
Authors: Klegeris A.; Walker D.G.; McGeer P.L.

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier
pp. 1027-1034(8)
Authors: Tyler B.M.; Douglas C.L.; Fauq A.; Pang Y.-P.; Stewart J.A.; Cusack B.; McCormick D.J.; Richelson E.

Modulation of 5-HT_1A receptor signalling by point-mutation of cysteine³⁵¹ in the rat G_o protein
pp. 1035-1041(7)
Authors: Dupuis D.S.; Tardif S.; Wurch T.; Colpaert F.C.; Pauwels P.J.

Effects of PNU-109,291, a selective 5-HT_1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis
pp. 1043-1053(11)
Authors: Cutrer F.M.; Yu X.-J.; Ayata G.; Moskowitz M.A.; Waeber C.

Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action
pp. 1055-1061(7)
Authors: Scorza C.; Silveira R.; Nichols D.; Reyes-Parada M.

Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain
pp. 1063-1073(11)
Authors: Zetterstrom T.S.C.; Pei Q.; Madhav T.R.; Coppell A.L.; Lewis L.; Grahame-Smith D.G.

Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine
pp. 1075-1082(8)
Authors: Riva M.A.; Molteni R.; Tascedda F.; Massironi A.; Racagni G.